Endocrine

On this page 6 sections
Insulin
| Type | Examples | Main idea |
|---|---|---|
| Rapid | Lispro, aspart, glulisine | Meal-time |
| Short | Regular | ⭐ IV use; DKA |
| Intermediate | NPH | Intermediate/basal |
| Long | Glargine, detemir, degludec | Basal |
DIABETES
| Class | Example | Main mechanism | Classic adverse effect |
|---|---|---|---|
| Insulin | Regular, glargine | ↑ glucose uptake | ⭐ Hypoglycemia |
| Biguanide | Metformin | ↓ hepatic gluconeogenesis | GI effects, B12 ↓ |
| Sulfonylurea | Glipizide | ↑ insulin secretion | ⭐ Hypoglycemia + weight gain |
| Meglitinide | Repaglinide | ↑ insulin secretion | Hypoglycemia |
| TZD | Pioglitazone | ↑ insulin sensitivity | ⭐ Edema + weight gain |
| α-glucosidase inhibitor | Acarbose | ↓ carb absorption | ⭐ Flatulence |
| DPP-4 inhibitor | Sitagliptin | ↑ incretin action | Generally well tolerated |
| GLP-1 agonist | Semaglutide | ↑ insulin, ↓ glucagon, ↑ satiety | ⭐ Nausea |
| SGLT2 inhibitor | Empagliflozin | ↑ urinary glucose excretion | ⭐ Genital infections |
Thyroid Drugs
METHIMAZOLE vs PTU
| Methimazole | PTU | |
|---|---|---|
| TPO inhibition | ✅ | ✅ |
| ↓ T₄ → T₃ | ❌ | ⭐ ✅ |
| Hepatotoxicity | Less prominent | ⭐⭐⭐ Important |
| Agranulocytosis | Possible | Possible |
| First-line generally | ⭐ Yes | No |
| Pregnancy | Avoid in 1st trimester when possible | ⭐ Preferred in 1st trimester |
THYROID MASTER TABLE
| Drug | Mechanism | Classic association |
|---|---|---|
| Levothyroxine | T₄ replacement | ⭐ Hypothyroidism |
| Methimazole | TPO inhibitor | ⭐ First-line hyperthyroidism |
| PTU | TPO inhibitor + ↓ T₄→T₃ | ⭐ Thyroid storm / 1st trimester |
| Iodide | ↓ hormone release | ⭐ Thyroid storm |
| Radioactive I-131 | Destroys thyroid tissue | ⭐ Definitive treatment |
| Propranolol | β-blockade + ↓ T₄→T₃ | ⭐ Symptom control |
PITUITARY MASTER TABLE
| Hormone/problem | Drug | Mechanism |
|---|---|---|
| Central DI | Desmopressin | V₂ agonist |
| Hyponatremia | Tolvaptan | V₂ antagonist |
| Labor induction | Oxytocin | Uterine contraction |
| GH deficiency | Somatropin | GH replacement |
| Acromegaly | Octreotide | ↓ GH secretion |
| Acromegaly | Pegvisomant | GH receptor antagonist |
| Hyperprolactinemia | Cabergoline | D₂ agonist |
| Prolactinoma | Bromocriptine/Cabergoline | ↓ prolactin |